| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000261068.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.016221372 |
Resistant |
| ENSG00000261068.1 |
Gefitinib |
Breast invasive carcinoma |
0.026623997 |
Sensitive |
| ENSG00000261068.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.017928203 |
Sensitive |
